GUANGZHOU BAYBIO BIO-TECH CO., LTD

Guangzhou Baybio Bio-Tech Co., Ltd. specializes in producing nucleic acid extraction and isolation kits designed for in vitro diagnostic (IVD) use. These include both manual and automated systems, such as the *Baybio Automated Nucleic Acid Isolation System*, which are intended for processing biological samples in laboratory settings to isolate nucleic acids for downstream diagnostic applications.

The company is headquartered in China, specifically in Guangzhou. This geographic location influences its regulatory compliance requirements, particularly for markets like the EU where additional documentation or conformity assessments may apply.

Yes, the company’s devices are listed in the EUDAMED registry, which is the European Union’s database for medical devices. Listing in EUDAMED is required for devices placed on the EU market, ensuring transparency about their regulatory status and manufacturer details.

Under EU regulations, the company’s nucleic acid extraction/isolation kits are classified as Class A devices. This classification is determined by the risk associated with the device’s intended use—low risk in this case—and dictates the regulatory pathway, such as self-certification under the Medical Device Regulation (MDR) or In Vitro Diagnostic Regulation (IVDR).